Skip to content

Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke

Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02971826
Acronym
REVIVE SE
Enrollment
1
Registered
2016-11-23
Start date
2018-11-30
Completion date
2019-06-01
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, thrombectomy, REVIVETM SE, MRI, Computed Tomography

Brief summary

The last marketed thrombectomy devices, named stentretriever, permit a better and faster recanalization in patient with a stroke. The REVIVETM SE is a device designed to restore the brain perfusion in patient with an intracranial artery occlusion. The REVIVETM Se device is not widely use in Europe and in France. The objective of this study is to assess the interest of using this device in the standard care of ischemic stroke in the radiology unit of the hospital Pierre Wertheimer, Lyon. The medical care will not be modified but data will be collected in order to determine whether or not this device is useful for the practice of the radiology unit.

Interventions

DEVICEREVIVETM SE thrombectomy

Mechanical thrombectomy using the REVIVETM SE device in patient with an ischemic stroke due to an intracranial arterial occlusion

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with an ischemic stroke detected by Computed Tomography (CT) or Magnetic Resonance Image (MRI) * Large proximal arterial occlusion : M1 segment of the Middle cerebral artery (MCA), Internal Carotid Artery (ICA) or Basilar Artery (BA) * Last known well (without neurological symptoms) ≤ 8 hours of treatment initiation * Score NIHSS ≥4 * Eligibility on an endovascular procedure using REVIVETM SE device * No opposition of the patient to participate at the study

Exclusion criteria

* Diagnostic cerebral imaging impossible * Distal occlusion * Tortuous vessel or other specificity preventing the access of device * Vessel diameter \< 1.5 mm * Known hypersensibility or allergy to nitinol * Subjects not covered by or having the right to social security * Deprivation of civil rights (guardianship, safeguard justice)

Design outcomes

Primary

MeasureTime frameDescription
number of patients with a TICI score of 2b or 3 just after the thrombectomyup to 2 daysThe TICI score is a grading system which evaluate the degree of reperfusion as seen on arteriography

Secondary

MeasureTime frameDescription
Number of the other devices use during the thrombectomy (Gidewire, catheter, etc.)up to 2 daysReview of the medical report which collected the devices used
Number of other procedures to treat the patient (thrombolysis, thromboaspiration, etc)Day 0Review of the medical report which collected the acute treatments
Time to obtain the appropriate recanalization (TICI 2b or 3)At the end of the procedure - Day 0Time of recanalization reported by the investigator on the medical report

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026